![](https://endpts.com/wp-content/uploads/2019/07/Christi-Shaw-endpts-tile-Jeff-Rumans-JPM19.jpg)
Christi Shaw, Kite CEO (Jeff Rumans for Endpoints News)
Gilead's Kite earns second-line win for CAR-T Yescarta, setting up a battle over earlier blood cancer patients
Bristol Myers Squibb shook the CAR-T field earlier this month with a breakthrough win in earlier-line blood cancer patients with the promise of changing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.